Live feed
Filing
SC 13G
SC 13G0001104659-16-110585·Corvus Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Corvus Pharmaceuticals Inc
Security class unavailable · CUSIP: 221015100
Event date: 2016-03-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,067,826
- Percent of class
- 5.2300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-16-110585
- Form type
- SC 13G
- Filer
- Corvus Pharmaceuticals, Inc.
- CIK
- CIK 1626971
- Filed
- Apr 08, 2016
- Reporting period
- Mar 22, 2016
- Description
- Schedule 13G beneficial ownership